Most Referenced Publications Archives - CureVac

Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines

mRNA mediates passive vaccination against infectious agents, toxins, and tumors

Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial

A New RNA-Based Adjuvant Enhances Virus-Specific Vaccine Responses by Locally Triggering TLR- and RLH-Dependent Effects

A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profile

Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals